Literature Review On Infliximab

According to Murray, some patients fight death, they use drugs, chemotherpy, radiation, surgical, or CPR. They believe that they can overcome their illness. Doctors recommend that people who can not be saved with treatment should just live their life with their family, enjoying the rest of their days. Therefore, the doctors have to know what is best for their patients. They should have treatment. When the patients spend a lot of money, this is not the way to overcome illness. For example, there was a women trying to overcome her

I. Imagine yourself or a loved one just diagnosed with a terminal debilitating illness. You are given at best six months to live. During those six months your prognosis will turn from bad to worse. You know you will eventually be in an uncontrollable amount of persistent pain. You will eventually lose the ability to feed, dress, or bathe and toilet yourself. Your once very active life will become one

Many experts in healthcare economics point out that chronic medical conditions are directly associated with higher costs (G., 2010). This association is mainly attributed to the high usage of all types of care (Kongstvedt, 2013). Reports show that the number of people suffering with chronic conditions is radically rising and forecasts suggest that the number of American’s with one or more chronic conditions will continue to grow by an estimated 37% between 2000 and 2030 (G., 2010). It is in our patient’s main interest to shift our current focus from treatment for acute conditions to target a better utilization of the recorded 78% of health spending devoted to people with chronic conditions. The new strategic approach is one of developing quality medical care for people with chronic conditions which require ongoing care and care management to improve their health status (Kongstvedt, 2013).

In addition to exploring and identifying contributing factors to health-related quality of life or HRQL, Gorecki et al also determined if there is a relationship between health-related quality of life (HRQL) outcomes and these contributing factors. While this latter objective cannot be quantitatively determined, Gorecki et al have determined from their study that there are indications that indeed, HRQL outcomes are influenced by the identified contributing factors among PU patients. The contributing factors discovered and identified in the study were the

Health professionals quite often have to weigh p agreements over cost, the effectiveness of treatment and the benefit that patients gain from the proposed course of action.

Apart from all this, there are however situations where such dilemmas are properly addressed and the patient automatically demonstrates a prompt tendency to show recovery from the disease he or she was initially suffering from.

Health care economics involves making plenty of choices. Individuals, groups, businesses, and organizations choose how to use resources . Economics and health care are linked, because health care professionals apply economics in their everyday professional activities. They are able to do this through resource allocation. Any health care organization has to plan out how they will use their resources to their advantage. Health care economics are able to incorporate terms like cost, quality, and resources. In this paper, I will compare these terms as they relate to health care economics. In this paper, I will also explain how they

There are 10 key economic concepts of health care. Each of the economic concepts is important when evaluating the different issues related to health care such as the increasing cost of health care. Henderson (2015), list the 10 concepts as follows: scarcity and choice, opportunity cost, marginal analysis, self-interest, markets and pricing, supply and demand, competition, efficiency, market failure, and comparative, advantage. The concept scarcity and choice address the issues related to the limited supply resources and the need to economize (Henderson, 2015). An illustration of the importance of the scarcity and choice concept is when there is a low quantity of available resources to meet the demand of individuals and rationing occurs. Opportunity cost emphasizes

This article was quite different from the previous articles I have read in the class as it poses methods for physicians to analyze treatment benefits. Similar to what we learned in class, the article discusses different types of economic analysis as well as the different types of costs associated with treatments. Although I think that considering economic analysis is a great way for physicians to provide the most beneficial treatment, I

The cost analysis is used for side effects, illnesses, and interventions/programs. The cost analysis includes the monetary analysis of communicable diseases, outbreaks, cancers, and interventions/programs.

Since the NHS is a publicly funded healthcare system, healthcare costs are rising and the NHS foundation trusts are facing a deficit of £321m, a policy that assesses the cost-effectiveness of interventions is highly important. (NHS foundation trusts, 2015) Cost-effectiveness looks at drugs and treatments through an economic lens: how much do they cost and what do they cost compared to alternatives? Is it worth the cost? NICE assesses the cost-effectiveness of interventions based on a cost-utility analysis that compares the costs against the gains in the expected health outcome. The use of cost-effectiveness is about getting value for money. NICE uses the quality-adjusted life year (QALY) metric, which combines the length of life and health-related

Against a background of increasing demands on limited resources, health economics is exerting an influence on decision making at all levels of health care. Health economics seeks to facilitate decision making by offering an explicit decision making framework based on the principle of efficiency. It is not the only consideration but it is an important one and practitioners will need to have an understanding of its basic principles and how it can impact on clinical decision making.

Cost-benefit, cost-effectiveness and cost-utility analyses are forms of economic evaluation which are useful in health economics for comparing costs and allocating resources. Health economics is widely relevant to governments and the health sector in implementation of new policy, as it concerns the allocation of resources in the context of a limited budget, or 'scarcity'. Economic evaluation is a potential tool for setting priorities in health, though it is only one of many potential criteria, including overall budget and public attitudes and wants. Economic evaluation is already in use in some settings, such as in pharmaceutical company proposals for government subsidisation, but there is room for expansion across the field of

The current research programs in the Centre for Health Economic at Monash University took my interest as the university is providing a wide range of research areas in the field of Health Economics. Furthermore, the researches are mainly centred on economic evaluation, health outcomes and performance in the health care system which help me to get a comprehensive knowledge and understanding of micro econometrics and other statistical methods, while focusing on Health Economics. In addition to my postgraduate experience, during my volunteer work at King Edward Memorial Hospital and Multiple Sclerosis Society of Western Australia, I have acquired experience in designing questionnaires in relation to ongoing health programs and analysed the surveys’ data focusing on pre-and post-health outcomes. All these academic and extracurricular activities enhance my interest in Health Economics and therefore I am willing to go for further studies to have a sound knowledge of in this specific field.

The first step in Cellini and Kee's framework is to determine if the analysis will be cost-benefit or cost-effectiveness. Cost benefit analysis is considered by the authors to be the superior technique (p.496) so that is what will be used. The